Copyright Reports & Markets. All rights reserved.

Global Biodegradable Embolic Microspheres Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Biodegradable Embolic Microspheres Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Visualization Type
    • 1.3.3 Radioactive Type
    • 1.3.4 Environmentally Responsive Type
    • 1.3.5 Other
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Biodegradable Embolic Microspheres Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospitals And Clinics
    • 1.4.3 Research Institution
  • 1.5 Global Biodegradable Embolic Microspheres Market Size & Forecast
    • 1.5.1 Global Biodegradable Embolic Microspheres Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Biodegradable Embolic Microspheres Sales Quantity (2021-2032)
    • 1.5.3 Global Biodegradable Embolic Microspheres Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Biocompatibles
    • 2.1.1 Biocompatibles Details
    • 2.1.2 Biocompatibles Major Business
    • 2.1.3 Biocompatibles Biodegradable Embolic Microspheres Product and Services
    • 2.1.4 Biocompatibles Biodegradable Embolic Microspheres Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Biocompatibles Recent Developments/Updates
  • 2.2 Nippon Kayaku
    • 2.2.1 Nippon Kayaku Details
    • 2.2.2 Nippon Kayaku Major Business
    • 2.2.3 Nippon Kayaku Biodegradable Embolic Microspheres Product and Services
    • 2.2.4 Nippon Kayaku Biodegradable Embolic Microspheres Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Nippon Kayaku Recent Developments/Updates
  • 2.3 Varian
    • 2.3.1 Varian Details
    • 2.3.2 Varian Major Business
    • 2.3.3 Varian Biodegradable Embolic Microspheres Product and Services
    • 2.3.4 Varian Biodegradable Embolic Microspheres Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Varian Recent Developments/Updates
  • 2.4 Next Biomedical
    • 2.4.1 Next Biomedical Details
    • 2.4.2 Next Biomedical Major Business
    • 2.4.3 Next Biomedical Biodegradable Embolic Microspheres Product and Services
    • 2.4.4 Next Biomedical Biodegradable Embolic Microspheres Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Next Biomedical Recent Developments/Updates
  • 2.5 Mermaid Medical
    • 2.5.1 Mermaid Medical Details
    • 2.5.2 Mermaid Medical Major Business
    • 2.5.3 Mermaid Medical Biodegradable Embolic Microspheres Product and Services
    • 2.5.4 Mermaid Medical Biodegradable Embolic Microspheres Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Mermaid Medical Recent Developments/Updates
  • 2.6 CeloNova BioSciences
    • 2.6.1 CeloNova BioSciences Details
    • 2.6.2 CeloNova BioSciences Major Business
    • 2.6.3 CeloNova BioSciences Biodegradable Embolic Microspheres Product and Services
    • 2.6.4 CeloNova BioSciences Biodegradable Embolic Microspheres Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 CeloNova BioSciences Recent Developments/Updates
  • 2.7 Biosphere Medical
    • 2.7.1 Biosphere Medical Details
    • 2.7.2 Biosphere Medical Major Business
    • 2.7.3 Biosphere Medical Biodegradable Embolic Microspheres Product and Services
    • 2.7.4 Biosphere Medical Biodegradable Embolic Microspheres Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Biosphere Medical Recent Developments/Updates
  • 2.8 Promedics AG
    • 2.8.1 Promedics AG Details
    • 2.8.2 Promedics AG Major Business
    • 2.8.3 Promedics AG Biodegradable Embolic Microspheres Product and Services
    • 2.8.4 Promedics AG Biodegradable Embolic Microspheres Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Promedics AG Recent Developments/Updates
  • 2.9 Merit Medical Systems
    • 2.9.1 Merit Medical Systems Details
    • 2.9.2 Merit Medical Systems Major Business
    • 2.9.3 Merit Medical Systems Biodegradable Embolic Microspheres Product and Services
    • 2.9.4 Merit Medical Systems Biodegradable Embolic Microspheres Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Merit Medical Systems Recent Developments/Updates
  • 2.10 ABK Biomedical
    • 2.10.1 ABK Biomedical Details
    • 2.10.2 ABK Biomedical Major Business
    • 2.10.3 ABK Biomedical Biodegradable Embolic Microspheres Product and Services
    • 2.10.4 ABK Biomedical Biodegradable Embolic Microspheres Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 ABK Biomedical Recent Developments/Updates
  • 2.11 BTG Corporate
    • 2.11.1 BTG Corporate Details
    • 2.11.2 BTG Corporate Major Business
    • 2.11.3 BTG Corporate Biodegradable Embolic Microspheres Product and Services
    • 2.11.4 BTG Corporate Biodegradable Embolic Microspheres Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 BTG Corporate Recent Developments/Updates
  • 2.12 Teleflex
    • 2.12.1 Teleflex Details
    • 2.12.2 Teleflex Major Business
    • 2.12.3 Teleflex Biodegradable Embolic Microspheres Product and Services
    • 2.12.4 Teleflex Biodegradable Embolic Microspheres Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Teleflex Recent Developments/Updates
  • 2.13 Terumo Corporation
    • 2.13.1 Terumo Corporation Details
    • 2.13.2 Terumo Corporation Major Business
    • 2.13.3 Terumo Corporation Biodegradable Embolic Microspheres Product and Services
    • 2.13.4 Terumo Corporation Biodegradable Embolic Microspheres Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Terumo Corporation Recent Developments/Updates
  • 2.14 Tepha
    • 2.14.1 Tepha Details
    • 2.14.2 Tepha Major Business
    • 2.14.3 Tepha Biodegradable Embolic Microspheres Product and Services
    • 2.14.4 Tepha Biodegradable Embolic Microspheres Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Tepha Recent Developments/Updates
  • 2.15 Angio Dynamics
    • 2.15.1 Angio Dynamics Details
    • 2.15.2 Angio Dynamics Major Business
    • 2.15.3 Angio Dynamics Biodegradable Embolic Microspheres Product and Services
    • 2.15.4 Angio Dynamics Biodegradable Embolic Microspheres Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Angio Dynamics Recent Developments/Updates
  • 2.16 Occlugel
    • 2.16.1 Occlugel Details
    • 2.16.2 Occlugel Major Business
    • 2.16.3 Occlugel Biodegradable Embolic Microspheres Product and Services
    • 2.16.4 Occlugel Biodegradable Embolic Microspheres Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Occlugel Recent Developments/Updates
  • 2.17 Jiangsu Hengrui Medicine
    • 2.17.1 Jiangsu Hengrui Medicine Details
    • 2.17.2 Jiangsu Hengrui Medicine Major Business
    • 2.17.3 Jiangsu Hengrui Medicine Biodegradable Embolic Microspheres Product and Services
    • 2.17.4 Jiangsu Hengrui Medicine Biodegradable Embolic Microspheres Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Jiangsu Hengrui Medicine Recent Developments/Updates

3 Competitive Environment: Biodegradable Embolic Microspheres by Manufacturer

  • 3.1 Global Biodegradable Embolic Microspheres Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Biodegradable Embolic Microspheres Revenue by Manufacturer (2021-2026)
  • 3.3 Global Biodegradable Embolic Microspheres Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Biodegradable Embolic Microspheres by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Biodegradable Embolic Microspheres Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Biodegradable Embolic Microspheres Manufacturer Market Share in 2025
  • 3.5 Biodegradable Embolic Microspheres Market: Overall Company Footprint Analysis
    • 3.5.1 Biodegradable Embolic Microspheres Market: Region Footprint
    • 3.5.2 Biodegradable Embolic Microspheres Market: Company Product Type Footprint
    • 3.5.3 Biodegradable Embolic Microspheres Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Biodegradable Embolic Microspheres Market Size by Region
    • 4.1.1 Global Biodegradable Embolic Microspheres Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Biodegradable Embolic Microspheres Consumption Value by Region (2021-2032)
    • 4.1.3 Global Biodegradable Embolic Microspheres Average Price by Region (2021-2032)
  • 4.2 North America Biodegradable Embolic Microspheres Consumption Value (2021-2032)
  • 4.3 Europe Biodegradable Embolic Microspheres Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Biodegradable Embolic Microspheres Consumption Value (2021-2032)
  • 4.5 South America Biodegradable Embolic Microspheres Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Biodegradable Embolic Microspheres Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Biodegradable Embolic Microspheres Sales Quantity by Type (2021-2032)
  • 5.2 Global Biodegradable Embolic Microspheres Consumption Value by Type (2021-2032)
  • 5.3 Global Biodegradable Embolic Microspheres Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Biodegradable Embolic Microspheres Sales Quantity by Application (2021-2032)
  • 6.2 Global Biodegradable Embolic Microspheres Consumption Value by Application (2021-2032)
  • 6.3 Global Biodegradable Embolic Microspheres Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Biodegradable Embolic Microspheres Sales Quantity by Type (2021-2032)
  • 7.2 North America Biodegradable Embolic Microspheres Sales Quantity by Application (2021-2032)
  • 7.3 North America Biodegradable Embolic Microspheres Market Size by Country
    • 7.3.1 North America Biodegradable Embolic Microspheres Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Biodegradable Embolic Microspheres Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Biodegradable Embolic Microspheres Sales Quantity by Type (2021-2032)
  • 8.2 Europe Biodegradable Embolic Microspheres Sales Quantity by Application (2021-2032)
  • 8.3 Europe Biodegradable Embolic Microspheres Market Size by Country
    • 8.3.1 Europe Biodegradable Embolic Microspheres Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Biodegradable Embolic Microspheres Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Biodegradable Embolic Microspheres Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Biodegradable Embolic Microspheres Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Biodegradable Embolic Microspheres Market Size by Region
    • 9.3.1 Asia-Pacific Biodegradable Embolic Microspheres Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Biodegradable Embolic Microspheres Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Biodegradable Embolic Microspheres Sales Quantity by Type (2021-2032)
  • 10.2 South America Biodegradable Embolic Microspheres Sales Quantity by Application (2021-2032)
  • 10.3 South America Biodegradable Embolic Microspheres Market Size by Country
    • 10.3.1 South America Biodegradable Embolic Microspheres Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Biodegradable Embolic Microspheres Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Biodegradable Embolic Microspheres Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Biodegradable Embolic Microspheres Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Biodegradable Embolic Microspheres Market Size by Country
    • 11.3.1 Middle East & Africa Biodegradable Embolic Microspheres Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Biodegradable Embolic Microspheres Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Biodegradable Embolic Microspheres Market Drivers
  • 12.2 Biodegradable Embolic Microspheres Market Restraints
  • 12.3 Biodegradable Embolic Microspheres Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Biodegradable Embolic Microspheres and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Biodegradable Embolic Microspheres
  • 13.3 Biodegradable Embolic Microspheres Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Biodegradable Embolic Microspheres Typical Distributors
  • 14.3 Biodegradable Embolic Microspheres Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Biodegradable Embolic Microspheres market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Biodegradable Embolic Microspheres are indicated for use in hemostatic embolization and in embolization of arteriovenous malformations, hypervascular tumors, including uterine fibroids and meningiomas, and the prostate arteries for relief of symptoms related to Benign Prostatic Hyperplasia (BPH).
    This report is a detailed and comprehensive analysis for global Biodegradable Embolic Microspheres market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Biodegradable Embolic Microspheres market size and forecasts, in consumption value ($ Million), sales quantity (K Tons), and average selling prices (US$/Ton), 2021-2032
    Global Biodegradable Embolic Microspheres market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Tons), and average selling prices (US$/Ton), 2021-2032
    Global Biodegradable Embolic Microspheres market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Tons), and average selling prices (US$/Ton), 2021-2032
    Global Biodegradable Embolic Microspheres market shares of main players, shipments in revenue ($ Million), sales quantity (K Tons), and ASP (US$/Ton), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Biodegradable Embolic Microspheres
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Biodegradable Embolic Microspheres market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Biocompatibles, Nippon Kayaku, Varian, Next Biomedical, Mermaid Medical, CeloNova BioSciences, Biosphere Medical, Promedics AG, Merit Medical Systems, ABK Biomedical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Biodegradable Embolic Microspheres market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Visualization Type
    Radioactive Type
    Environmentally Responsive Type
    Other
    Market segment by Application
    Hospitals And Clinics
    Research Institution
    Major players covered
    Biocompatibles
    Nippon Kayaku
    Varian
    Next Biomedical
    Mermaid Medical
    CeloNova BioSciences
    Biosphere Medical
    Promedics AG
    Merit Medical Systems
    ABK Biomedical
    BTG Corporate
    Teleflex
    Terumo Corporation
    Tepha
    Angio Dynamics
    Occlugel
    Jiangsu Hengrui Medicine
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Biodegradable Embolic Microspheres product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Biodegradable Embolic Microspheres, with price, sales quantity, revenue, and global market share of Biodegradable Embolic Microspheres from 2021 to 2026.
    Chapter 3, the Biodegradable Embolic Microspheres competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Biodegradable Embolic Microspheres breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Biodegradable Embolic Microspheres market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Biodegradable Embolic Microspheres.
    Chapter 14 and 15, to describe Biodegradable Embolic Microspheres sales channel, distributors, customers, research findings and conclusion.

    Buy now